| Title | American Journal of Cardiovascular Drugs |
| Abbreviation | Am. J. Cardiovasc. Drugs |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2) |
| h-index | 63 |
| Overall Rank/Ranking | 5925 |
| SCImago Journal Rank (SJR) | 0.876 |
| Impact Score | 2.80 |
| Publisher | |
| Country | Switzerland |
| ISSN | 11753277, 1179187X |
| Best Quartile | Q2 |
| Coverage History | 2001-2025 |
American Journal of Cardiovascular Drugs is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2). It is published by . The overall rank of American Journal of Cardiovascular Drugs is 5925. According to SCImago Journal Rank (SJR), this journal is ranked 0.876. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 63. The best quartile for this journal is Q2.
The ISSN of American Journal of Cardiovascular Drugs journal is 11753277, 1179187X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. American Journal of Cardiovascular Drugs is cited by a total of 525 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of American Journal of Cardiovascular Drugs is 2.80, which is computed in 2025 as per its definition. American Journal of Cardiovascular Drugs IF is increased by a factor of 0.14 and approximate percentage change is 5.26% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of American Journal of Cardiovascular Drugs is 2.80. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.80 |
| 2023 | 2.66 |
| 2022 | 3.12 |
| 2021 | 3.56 |
| 2020 | 2.86 |
| 2019 | 2.60 |
| 2018 | 2.40 |
| 2017 | 2.85 |
| 2016 | 2.98 |
| 2015 | 2.49 |
| 2014 | 2.60 |
American Journal of Cardiovascular Drugs has an h-index of 63. It means 63 articles of this journal have more than 63 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of American Journal of Cardiovascular Drugs is 11753277, 1179187X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of American Journal of Cardiovascular Drugs is 5925. According to SCImago Journal Rank (SJR), this journal is ranked 0.876. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.876 |
| 2023 | 0.79 |
| 2022 | 0.841 |
| 2021 | 1.010 |
| 2020 | 1.063 |
| 2019 | 0.854 |
| 2018 | 0.903 |
| 2017 | 0.951 |
| 2016 | 0.927 |
| 2015 | 0.920 |
| 2014 | 0.992 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5925 |
| 2023 | 6332 |
| 2022 | 5546 |
| 2021 | 4040 |
| 2020 | 3987 |
| 2019 | 5437 |
| 2018 | 5003 |
| 2017 | 4667 |
| 2016 | 4876 |
| 2015 | 4962 |
| 2014 | 4385 |
American Journal of Cardiovascular Drugs is published by . It's publishing house is located in Switzerland. Coverage history of this journal is as following: 2001-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of American Journal of Cardiovascular Drugs is Am. J. Cardiovasc. Drugs. This abbreviation ('Am. J. Cardiovasc. Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
American Journal of Cardiovascular Drugs latest impact IF is 2.80. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.56 (2021) and 2.40 (2018), respectively, in the last 11 years. Moreover, its average IS is 2.81 in the previous 11 years.
The American Journal of Cardiovascular Drugs has an SJR (SCImago Journal Rank) of 0.876, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.063 in 2020 and the lowest being 0.79 in 2023. Furthermore, the average SJR of the American Journal of Cardiovascular Drugs over the previous 11-year period stands at 2.81.
The latest h-index of the American Journal of Cardiovascular Drugs is 63.
The American Journal of Cardiovascular Drugs is published by the , with its country of publication being the Switzerland.
The American Journal of Cardiovascular Drugs is currently ranked 5925 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3987 in 2020 and its lowest position of 6332 in 2023.
The standard ISO4 abbreviation for the American Journal of Cardiovascular Drugs is Am. J. Cardiovasc. Drugs.
American Journal of Cardiovascular Drugs is classified as a journal that the publishes.
The American Journal of Cardiovascular Drugs encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The American Journal of Cardiovascular Drugs is assigned the following International Standard Serial Numbers (ISSN): 11753277, 1179187X.
The best quartile for the American Journal of Cardiovascular Drugs is Q2 (2024).
The American Journal of Cardiovascular Drugs coverage history can be summarized as follows: 2001-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9811 | Vilnius Gediminas Technical University | 55 | 2.84 |
| Journal of Field Archaeology | journal | 7683 | Maney Publishing | 48 | 1.85 |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 29148 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Indian Phytopathology | journal | 16772 | Springer | 20 | 0.91 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.80 |
| 2023 | 2.66 |
| 2022 | 3.12 |
| 2021 | 3.56 |
| 2020 | 2.86 |
| 2019 | 2.60 |
| 2018 | 2.40 |
| 2017 | 2.85 |
| 2016 | 2.98 |
| 2015 | 2.49 |
| 2014 | 2.60 |
